Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro.
Influenza viruses cause respiratory tract infections and substantial health concerns. Infection may result in mild to severe respiratory disease associated with morbidity and some mortality. Several anti-influenza drugs are available, but these agents target viral components and are susceptible to d...
Guardado en:
Autores principales: | Nichole Orr-Burks, Jackelyn Murray, Kyle V Todd, Abhijeet Bakre, Ralph A Tripp |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f17196fd9e31483587a1a73b98858bbd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro
por: Nichole Orr-Burks, et al.
Publicado: (2021) -
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro
por: Jackelyn Murray, et al.
Publicado: (2021) -
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Ingrid Langer, et al.
Publicado: (2021) -
Prediction of drug-target interactions and drug repositioning via network-based inference.
por: Feixiong Cheng, et al.
Publicado: (2012) -
Evaluation of connectivity map shows limited reproducibility in drug repositioning
por: Nathaniel Lim, et al.
Publicado: (2021)